Document:

Stock Purchase Agreement

 Exhibit 10.1 
 STOCK PURCHASE AGREEMENT 
 STOCK PURCHASE AGREEMENT (the “Agreement”), dated as of
December 17, 2006, by and between WEIGHT WATCHERS INTERNATIONAL, INC., a Virginia corporation (the “Company”), and ARTAL HOLDINGS Sp. Z o.o., a corporation organized and existing under the laws of Poland
(“Artal”). 
 R E C I T A L S 
 WHEREAS, the Company intends, but has not made any public announcement of such intention, to conduct a public modified Dutch auction self-tender offer for up to 8,3000,000 shares of its common stock, no par value per
share (“Common Stock”), at prices ranging from $47.00 to $54.00 per share pursuant to the terms and conditions set forth in the draft Offer to Purchase substantially in the form attached hereto as Annex A, as the same may be
revised, amended, modified or supplemented from time to time after the date hereof in accordance with Section 8 hereof (the “Tender Offer”), commencing no later than December 19, 2006; 
 WHEREAS, as of the date hereof, Artal owns of record 53,759,325 shares of Common Stock of the Company, which constitutes approximately 55.2% of the
issued and outstanding shares of Common Stock; 
 WHEREAS, Artal has determined it will not exercise its right to tender any of its shares of
Common Stock pursuant to the Tender Offer; and 
 WHEREAS, the Company and Artal desire to make certain covenants and agreements with one
another pursuant to this Agreement. 
 NOW THEREFORE, in consideration of the covenants and promises set forth herein, and for other good and
valuable consideration, the receipt and sufficiency of which are hereby acknowledged, the parties hereby agree as follows: 
 SECTION 1

 PURCHASE AND SALE OF THE SHARES; THE CLOSING 
 1.1 Purchase and Sale of Common Stock. Subject to the completion of the Tender Offer as set forth below and the other terms and conditions of this Agreement, and on the basis of the representations, warranties
and covenants set forth herein, Artal agrees to sell to the Company, and the Company agrees to purchase from Artal, such number of shares of Common Stock (rounded to the nearest whole number of shares) equal to the aggregate number of shares of
Common Stock purchased by the Company in the Tender Offer multiplied by a fraction, the numerator of which is 53,759,325 and the denominator of which is 43,717,750 (representing the outstanding shares of Common Stock held of record by Artal divided
by the outstanding shares of Common Stock held of record by all stockholders of the Company other than Artal, each as of November 30, 2006). The number of shares of Common Stock to be purchased from Artal by the Company pursuant to this
Section 1.1 is herein referred to as, the “Shares.” 
 1.2 Purchase Price. The “Per Share Purchase
Price” for the Shares shall be equal to the price per share paid by the Company for the shares of Common Stock tendered by 

 the holders of Common Stock in the Tender Offer. The “Purchase Price” shall equal the Per Share Purchase
Price specified in Section 1.2 multiplied by the number of Shares purchased by the Company from Artal pursuant to Section 1.1 of this Agreement. 
 1.3 The Closing. Subject to the terms and conditions hereof, the purchase and sale of the Shares contemplated by this Agreement (the “Closing”) will take place at the offices of Simpson
Thacher & Bartlett LLP, 425 Lexington Avenue, New York, New York 10017 at 10:00 a.m., New York City time on the eleventh business day following the expiration date of the Tender Offer (the “Successful Completion”), or
at such other later date or place as the parties shall mutually agree. At the Closing, (a) Artal will deliver to the Company certificates representing the Shares to be purchased by the Company duly endorsed or accompanied by stock powers duly
executed in blank and otherwise in form acceptable for transfer on the books of the Company, and (b) the Company shall deliver the Purchase Price to Artal by wire transfer of immediately available funds to one or more accounts specified by
Artal at least one business day prior to the Closing. 
 SECTION 2 
 REPRESENTATIONS AND WARRANTIES OF ARTAL 
 In order to induce the Company to enter into
this Agreement, Artal hereby represents and warrants to the Company as follows: 
 2.1 Ownership of Shares. Artal owns of record the
number of issued and outstanding shares of Common Stock set forth in the recitals to this Agreement. The Shares to be sold to the Company by Artal when delivered to the Company shall be free and clear of any liens, claims or encumbrances, including
rights of first refusal and similar claims except for restrictions of applicable state and federal securities laws. There are no restrictions on the transfer of such Shares imposed by any shareholder or similar agreement or any law, regulation or
order, other than applicable state and federal securities laws. 
 2.2 Authorization. Artal has full right, power and authority to
execute, deliver and perform this Agreement and to sell, assign and deliver the Shares to be sold by it to the Company. This Agreement is the legal, valid and, assuming due execution and delivery by the other parties hereto, binding obligation of
Artal, enforceable in accordance with its terms, except to the extent that the enforceability thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws, now or hereafter in effect, relating to, or
affecting the rights of creditors or creditors’ rights generally or by general principles of equity (regardless of whether such enforcement is considered in a proceeding at law or in equity). 
 2.3 No Violation; No Consent. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated
hereby by Artal (a) will not constitute a breach or violation of or default under any judgment, decree or order or any agreement or instrument of Artal or to which Artal is subject, (b) will not result in the creation or imposition of any
lien upon the Shares to be sold by Artal, and (c) will not require the consent of or notice to any governmental entity or any party to any contract, agreement or arrangement with Artal. 
  

 2 

 2.4 Brokerage. There are no claims for brokerage commissions or finder’s fees or similar
compensation in connection with the transactions contemplated by this Agreement based on any arrangement or agreement made by or on behalf of Artal. 
 SECTION 3 
 REPRESENTATIONS AND WARRANTIES OF THE COMPANY 
 In order to induce Artal to enter into this Agreement, the Company hereby represents and warrants as follows: 
 3.1 Organization and Corporate Power; Authorization. The Company is a corporation duly incorporated, validly existing and in good standing under
the laws of the Commonwealth of Virginia. The Company has the requisite power and authority to execute, deliver and perform this Agreement and to acquire the Shares. As of the Closing the Company will have sufficient capital to purchase the Shares
hereunder. The execution, delivery and performance of this Agreement and the consummation by the Company of the transactions contemplated hereby have been approved by a majority of the disinterested directors on the Board of Directors of the Company
and have been otherwise duly authorized by all requisite action on the part of the Company. This Agreement and any other agreements, instruments, or documents entered into by the Company pursuant to this Agreement have been duly executed and
delivered by the Company and are the legal, valid and, assuming due execution by the other parties hereto, binding obligations of the Company, enforceable against the Company in accordance with its terms except to the extent that the enforceability
thereof may be limited by applicable bankruptcy, insolvency, reorganization, moratorium or other similar laws, now or hereafter in effect, relating to, or affecting the rights of creditors or creditors’ rights generally or by general principles
of equity (regardless of whether such enforcement is considered in a proceeding at law or in equity). 
 3.2 Capital Stock. The
authorized capital stock of the Company consists of (a) 1,000,000,000 shares of Common Stock, of which 97,477,075 shares were issued and outstanding as of November 30, 2006, and (b) 250,000,000 shares of preferred stock, no par value
per share, of which none were issued and outstanding as of November 30, 2006. 
 3.3 No Violation; No Consent. The execution,
delivery and performance of this Agreement and the consummation of the transactions contemplated hereby by the Company (a) will not constitute a breach or violation of or default under any judgment, decree or order or any agreement or
instrument of the Company or to which the Company is subject, and (b) will not require the consent of or notice to any governmental entity or any party to any contract, agreement or arrangement with the Company. 
 3.4 Brokerage. Except as set forth in the draft Offer to Purchase attached hereto as Annex A, there are no claims for brokerage commissions
or finder’s fees or similar compensation in connection with the transactions contemplated by this Agreement based on any arrangement or agreement made by or on behalf of the Company. 
  

 3 

 SECTION 4 
 CONDITIONS TO THE COMPANY’S OBLIGATIONS 
 The obligations of the Company under Section 1 to
purchase the Shares at the Closing from Artal are subject to the fulfillment as of the Closing of each of the following conditions unless waived by the Company in accordance with Section 9.9: 
 4.1 Representations and Warranties. The representations and warranties of Artal contained in Article 2 shall be true and correct on and as of the
date of the Closing with the same effect as though such representations and warranties had been made on and as of the date of the Closing. 
 4.2 Performance. Artal shall have performed and complied in all material respects with all agreements, obligations, and conditions contained in this Agreement that are required to be performed or complied with by it on or before the
date of the Closing. 
 4.3 Tender Offer. The Successful Completion of the Tender Offer shall have occurred and the Company shall have
purchased shares of Common Stock pursuant thereto in accordance with the terms thereof. 
 4.4 Delivery of Certificates. Artal shall
have delivered all of the stock certificates representing the Shares to be sold by it at the Closing (or in lieu thereof an affidavit of lost certificate), free and clear of any liens, claims or encumbrances, along with all stock powers, assignments
or any other documents, instruments or certificates necessary for a valid transfer. 
 4.5 Further Assurances. No governmental
authority shall have advised or notified the Company that the consummation of the transactions contemplated hereunder would constitute a material violation of any applicable laws or regulations, which notification or advice shall not have been
withdrawn after the exhaustion of the Company’s good faith efforts to cause such withdrawal. 
 SECTION 5 
 CONDITIONS TO ARTAL’S OBLIGATIONS 
 The
obligations of Artal under Section 1 to sell the Shares at the Closing are subject to the fulfillment as of the Closing of each of the following conditions unless waived by Artal in accordance with Section 9.9: 
 5.1 Representations and Warranties. The representations and warranties of the Company contained in Article 3 shall be true and correct as of the
date of the Closing with the same effect as though such representations and warranties had been made on and as of the date of the Closing. 
 5.2 Performance. The Company shall have performed and complied in all material respects with all agreements, obligations and conditions contained in this Agreement that are required to be performed or complied with by it on or before
the date of the Closing. 
  

 4 

 5.3 Tender Offer. The Successful Completion of the Tender Offer shall have occurred and the
Company shall have purchased shares of Common Stock pursuant thereto in accordance with the terms thereof. 
 5.4 Further Assurances.
No governmental authority shall have advised or notified Artal that the consummation of the transactions contemplated hereunder would constitute a material violation of any applicable laws or regulations, which notification or advice shall not have
been withdrawn after the exhaustion of the Artal’s good faith efforts to cause such withdrawal. 
 SECTION 6 
 COVENANTS 
 6.1 No Purchase of Common
Stock. Until eleven business days following the expiration date of the Tender Offer, Artal agrees that it and its affiliates will not, directly or indirectly, purchase any shares of Common Stock. 
 6.2 No Sale of Common Stock. Except as contemplated hereunder, from the date hereof until the Closing or the termination of this Agreement, Artal
agrees, on behalf of itself and its affiliates, that it and its affiliates, directly or indirectly, will not sell any shares of Common Stock, including in the Tender Offer. 
 6.3 Closing Conditions. Artal and the Company shall use their commercially reasonable efforts to ensure that each of the conditions to Closing is
satisfied. 
 6.4 Withholding. The Purchase Price shall be paid free and clear of any and all U.S. federal, state, local or foreign
income or withholding taxes except as provided in this Section 6.4. If the Company reasonably determines, pursuant to Section 302(d) of Internal Revenue Code of 1986, as amended (the “Code”), that the sale of Shares
hereunder is properly treated as a “distribution” subject to Section 301 of the Code, the Company shall withhold an amount therefrom, such amount to be calculated based on the Company’s reasonable estimate of the Company’s
current and accumulated earnings and profits for the year in which the Closing occurs, as determined in accordance with Treasury Regulation Section 1.1441-3(c)(2)(ii). If Artal certifies as to its eligibility for a reduced rate of withholding
pursuant to an income tax treaty on IRS Form W-8BEN provided to the Company by Artal, any such withholding shall be made at such reduced rate. Any amount withheld by the Company in accordance with this Section 6.4 shall be remitted to the
appropriate taxing authority, and such remittance shall be treated for purposes of this Agreement as a payment of a portion of the Purchase Price to Artal. 
 SECTION 7 
 SURVIVAL OF REPRESENTATIONS AND WARRANTIES; LIMITATION ON LIABILITY 
 7.1 Survival. All representations and warranties hereunder shall survive the Closing. 
 7.2 Limitation on Liability. Notwithstanding the foregoing, in no event shall Artal’s liability for breach of the representations, warranties
and covenants exceed the Purchase Price to be paid by the Company to Artal. 
  

 5 

 SECTION 8 
 ARTAL CONSENT 
 8.1 Consent. Artal’s consent shall be required for any amendment to the terms of
the Tender Offer that (a) changes the type or amount of consideration per share offered to shareholders, (b) increases the aggregate number of shares of Common Stock sought in the Tender Offer in excess of 8,3000,000 (plus up to an
additional 2% of the outstanding shares of Common Stock), (c) materially alters any of the conditions of the Tender Offer contained in Section 7 of the Offer to Purchase (except in response to comments from the Securities and Exchange
Commission), adds any additional conditions to the Tender Offer (provided, however, that this shall in no way limit the Company’s ability to waive any such condition), or (d) extends the expiration date of the Tender Offer beyond
February 5, 2007, except, in each case, as required by law. 
 SECTION 9 
 MISCELLANEOUS 
 9.1 Adjustments. Wherever a particular number is specified
herein, including, without limitation, number of shares or price per share, such number shall be adjusted to reflect any stock dividends, stock-splits, reverse stock-splits, combinations or other reclassifications of stock or any similar
transactions and appropriate adjustments shall be made with respect to the relevant provisions of this Agreement so as to fairly and equitably preserve, as far as practicable, the original rights and obligations of the Company and Artal under this
Agreement. 
 9.2 Successors and Assigns. Except as otherwise expressly provided herein, the provisions hereof shall inure to the
benefit of, and be binding upon, the successor and assigns of the parties hereto. 
 9.3 Entire Agreement; Amendment. This Agreement
contains all the terms agreed upon among the parties with respect to the subject matter hereof and supersedes all prior agreements, arrangements and communications, whether oral or written with respect to such subject matter. Neither this Agreement
nor any provision hereof may be amended, changed or waived other than by a written instrument signed by the party against who enforcement of any such amendment, change or waiver is sought. For the avoidance of doubt, to the extent that any of the
terms and conditions of this Agreement are inconsistent with any of the terms and conditions contained in the Offer to Purchase, the terms of this Agreement will govern and the Offer to Purchase will be revised to be consistent with the terms of
this Agreement. 
 9.4 Cooperation. The Company and Artal shall, from and after the date hereof, cooperate in a reasonable manner to
effect the purposes of this Agreement. 
 9.5 Termination. The Company or Artal may terminate this Agreement if (a) the Tender
Offer is terminated without the purchase of any shares of Common Stock or (b) if the Tender Offer is not consummated by February 5, 2007; provided that the Company may not terminate this Agreement under this clause (b) unless
the Tender Offer is terminated. Upon termination of this Agreement pursuant to this Section 9.5, none of the parties hereto shall have any liability hereunder except for breaches of such party’s representations, warranties or covenants
occurring prior to the date of such termination. 
  

 6 

 9.6 Notices. All notices and all other communications hereunder shall be in writing and shall be
deemed given if delivered personally or sent by registered or certified mail, postage prepaid (return receipt requested), sent by facsimile (receipt of which is confirmed) or sent by a nationally recognized overnight courier to a party at the
following address (or at such other address for a party as shall be specified by like notice): 
 If to Artal: 
 Artal Holdings Sp. z o.o., Succursale de Luxembourg 
 105, Grand-Rue 
 L-1661 Luxemburg 
 Attention: Audrey Le Pit 
 Facsimile: (352) 22 42 59 22 
 with a copy to: 
 The Invus Group, LLC

 750 Lexington Avenue 
 New
York, New York 10022 
 Attention: Christopher Sobecki 
 Facsimile: 212-371-1829 
 and with a copy to: 
 Gibson, Dunn & Crutcher LLP 
 200
Park Avenue 
 47th Floor 
 New
York, New York 10166 
 Attention: Steven Shoemate, Esq. 
 Facsimile: (212) 351-5316 
 If to the Company: 
 Weight Watchers International, Inc. 
 11
Madison Avenue 
 New York, New York 10010 
 Attention: General Counsel 
 Facsimile: 212-589-2601 
  

 7 

 with a copy to: 
 Simpson Thacher & Bartlett LLP 
 425 Lexington Avenue 
 New York, NY 10017 
 Attention: Kenneth B.
Wallach, Esq. 
 Facsimile: 212-455-2502 
 Each
such notice or other communication shall be effective at the time of receipt if delivered personally or sent by facsimile (with receipt confirmed) or nationally recognized overnight courier (with receipt confirmed), or three (3) business days
after being mailed, registered or certified mail, postage prepaid, return receipt requested. 
 9.7 Severability. If any provision of
this Agreement shall be judicially determined to be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired thereby. 
 9.8 GOVERNING LAW; JURISDICTION. THIS AGREEMENT SHALL BE GOVERNED BY AND CONSTRUED AND ENFORCED IN ACCORDANCE WITH THE LAWS OF THE STATE OF NEW
YORK. Any legal action or other legal proceeding relating to this agreement or the enforcement of any provision of this agreement may be brought or otherwise commenced in any state or federal court sitting in the Borough of Manhattan of the City of
New York. Each party hereto agrees to the entry of an order to enforce any resolution, settlement, order or award made pursuant to this Section 9.2 by the state and federal courts sitting in the Borough of Manhattan of the City of New York and
in connection therewith hereby irrevocably waives, and agrees not to assert by way of motion, defense, or otherwise, in any such action or proceeding, any claim that it is not subject personally to the jurisdiction of the above-named courts, that
its property is exempt or immune from attachment or execution, that the action or proceeding is brought in an inconvenient forum, that the venue of the action is improper, or that this Agreement or the transactions contemplated by this Agreement may
not be enforced in or by any of the above-named courts. 
 9.9 Delays or Omissions. It is agreed that no delay or omission to exercise
any right, power or remedy accruing to any party upon any breach or default of any other party under this Agreement shall impair any such right, power or remedy, nor shall it be construed to be a waiver of any such breach or default, or any
acquiescence therein, or of any similar breach or default thereafter occurring; nor shall any waiver of any single breach or default be deemed a waiver of any other breach or default theretofore or thereafter occurring. It is further agreed that any
waiver, permit, consent or approval of any kind or character of any breach or default under this Agreement, or any waiver of any provisions or conditions of this Agreement must be in writing and shall be effective only to the extent specifically set
forth in writing, and that all remedies, either under this Agreement, by law or otherwise, shall be cumulative and not alternative. 
 9.10
Consents. Any permission, consent, or approval of any kind or character under this Agreement shall be in writing and shall be effective only to the extent specifically set forth in such writing. 
  

 8 

 9.11 Specific Performance. The parties hereto agree that irreparable damage would occur in the
event any provision of this Agreement was not performed in accordance with the terms hereof and that the parties shall be entitled to an injunction or injunctions to prevent or cure breaches of this Agreement and to enforce specifically the terms
and provisions of this Agreement in addition to any other remedy to which they are entitled at law or in equity, and any party sued for breach of this Agreement expressly waives any defense that a remedy in damages would be adequate. 
 9.12 Payment of Fees and Expenses. Each party shall be responsible for paying its own fees, costs and expenses in connection with this Agreement
and the transactions herein contemplated. 
 9.13 Construction of Agreement. No provision of this Agreement shall be construed against
either party as the drafter thereof. The titles of the Sections of this Agreement are for convenience of reference only and in no way define, limit, extend, or describe the scope of this Agreement or the intent of any of its provisions. 

9.14 Counterparts. This Agreement may be executed in any number of counterparts, each of which shall be an original, but all of which together
shall constitute one instrument. 
 [Signatures follow on next page] 
  

 9 

 IN WITNESS WHEREOF, the parties have caused this Stock Purchase Agreement to be duly executed and
delivered by their proper and duly authorized officers as of the day and year first written above. 
  

			
	WEIGHT WATCHERS INTERNATIONAL, INC.
		
	By:	 	 /s/ Jeffrey A. Fiarman

	Name:	 	Jeffrey A. Fiarman
	Title:	 	Executive Vice President, General Counsel and Secretary
	
	ARTAL HOLDINGS SP. Z O.O., represented by Artal Holdings Sp. Z o.o. Succursale de Luxembourg
		
	By:	 	 /s/ Audrey Le Pit

	Name:	 	Audrey Le Pit
	Title:	 	Branch Manager

 [Stock Purchase Agreement]Commitment Letter

 Exhibit 10.2 
  

					
	 CREDIT SUISSE SECURITIES (USA) LLC
                 Eleven Madison Avenue
                   New York, NY 10010
	  		 	 CREDIT SUISSE
 Eleven Madison Avenue
New York, NY 10010

 CONFIDENTIAL 
 December 18, 2006 
 Weight Watchers International, Inc. 
 11 Madison Avenue 
 New York, NY 10010 
  

			
	Attention:	 	Ann Sardini
		 	Chief Financial Officer

 Weight Watchers International, Inc. 
 Commitment Letter 
 Ladies and Gentlemen: 
 Reference is made to the Sixth Amended and Restated Credit Agreement dated as of May 8, 2006, as amended (the “Existing Credit
Agreement”) among Weight Watchers International, Inc., a Virginia corporation (the “Borrower” or “you”), the lenders party thereto and The Bank of Nova Scotia, as administrative agent.
Terms used but not defined in this commitment letter (including the Exhibits and the other attachments hereto, this “Commitment Letter”) shall have the meanings assigned thereto in the Existing Credit Agreement. 

You have advised Credit Suisse (“CS”) and Credit Suisse Securities (USA) LLC (“CS Securities” and,
together with CS and their respective affiliates, “Credit Suisse”, “we” or “us”) that you intend to (a) make a public tender offer to acquire, and enter into an agreement
with an affiliate of yours to acquire, a portion of your outstanding common stock, for an aggregate purchase price not to exceed $1,000,000,000 (the “Self Tender and Affiliate Purchase”) and (b) repay all outstanding
indebtedness under, and terminate, (i) the First Lien Credit Agreement dated as of December 16, 2005, among Weightwatchers.com, Inc., the lenders party thereto and CS, as administrative agent, and (ii) the Second Lien Credit Agreement
dated as of December 16, 2005, among Weightwatchers.com, Inc., the lenders party thereto and CS, as administrative agent. You have further advised us that, in connection therewith, (x) the Borrower will obtain incremental term A-1 loans
(the “Designated Additional Term A-1 Loans”) under the Existing Credit Agreement in an aggregate principal amount of up to $700,000,000 (of which up to $575,000,000 may be drawn in a second drawing on a date up to three weeks

 following the Closing Date), (y) the Borrower will obtain incremental term B loans (the “Designated
Additional Term B Loans” and, together with the Designated Additional Term A-1 Loans, the “Additional Term Loans”) under the Existing Credit Agreement in an aggregate principal amount of up to $500,000,000 and
(z) you propose to amend certain provisions of the Existing Credit Agreement to, among other things, permit the Self Tender and Affiliate Purchase, give effect to the Additional Term Loans and the incurrence of indebtedness pursuant thereto,
add an excess cash flow sweep as a mandatory prepayment as described under the heading “Mandatory Prepayments” in Exhibit A and to increase the interest rate margins for the revolving facility and the term loan A facility (and modify the
pricing grid) in the manner described under the heading “Changes in Interest Rate Margins and Commitment Fees” in Annex I to Exhibit A (the “Proposed Amendment”). 
 If the Proposed Amendment is not obtained, then you would not obtain the Additional Term Loans, but rather you would terminate the Existing Credit
Agreement, prepay all amounts outstanding thereunder and obtain the senior secured replacement credit facilities (the “Replacement Facilities”) described in the Summary of Principal Terms and Conditions attached hereto as
Exhibit A (the “Senior Facilities Term Sheet”). The Additional Term Loans and the Replacement Facilities are referred to collectively herein as the “Facilities”). 
 1. Commitments. 
 In
connection with the foregoing, (a) CS is pleased to advise you of its commitment to provide the entire principal amount of the Additional Term Loans and (b) CS Securities is pleased to advise you of its agreement to use commercially
reasonable efforts to arrange the Proposed Amendment, in each case upon the terms and subject to the conditions set forth in this Commitment Letter. In addition, if the Proposed Amendment is not obtained, CS is pleased to advise you of its
commitment to provide the entire principal amount of the Replacement Facilities upon the terms and subject to the conditions set forth or referred to in this Commitment Letter. 
 2. Titles and Roles. 
 You hereby appoint (i) CS Securities to act, and CS Securities hereby agrees to act, as sole bookrunner and sole lead arranger for the Facilities (the “Lead Arranger”), it being understood that the Borrower may,
with the consent of CS Securities, such consent not to be unreasonably withheld, appoint an additional financial institution as joint bookrunner and co-lead arranger along with CS Securities, and (ii) CS to act, and CS hereby agrees to act, as
sole administrative agent and sole collateral agent (the “Agent”), it being understood that the Borrower may instead select The Bank of Nova Scotia or, if reasonably acceptable to CS, another Lender, to act as the Agent, with
respect to the Replacement Facilities, in each case upon the terms and subject to the conditions set forth or referred to in this Commitment Letter. The Lead Arranger and the Agent, in such capacities, will perform the duties and exercise the
authority customarily performed and exercised by it in such roles. You agree that, (i) Credit Suisse will have “left” placement 
  

 2 

 in any and all marketing materials or other documentation used in connection with the Facilities and (ii) in no
event will Credit Suisse be entitled to less than 40% of the economics granted in this Commitment Letter and in the Fee Letter referred to below. You further agree that no other titles will be awarded and no compensation (other than that expressly
contemplated by this Commitment Letter and the Fee Letter referred to below) will be paid in connection with the Facilities or the Proposed Amendment unless you and we shall so agree. 
 3. Syndication. 
 We
reserve the right, prior to or after the execution of definitive documentation for the Facilities, to syndicate all or a portion of our commitments with respect to the Facilities to a group of banks, financial institutions and other institutional
lenders (together with CS, the “Lenders”) identified by us and approved by you (such approval not to be unreasonably withheld or delayed). We intend to commence syndication efforts promptly upon the execution of this
Commitment Letter, and you agree actively to assist us in completing a satisfactory syndication. Such assistance shall include (a) your using commercially reasonable efforts to ensure that any syndication efforts benefit materially from your
existing lending and investment banking relationships, (b) direct contact between senior management, representatives and advisors of you and the proposed Lenders, (c) assistance by you in the preparation of a Confidential Information
Memorandum for the Facilities and other marketing materials to be used in connection with the syndication, (d) prior to the launch of the syndication, the obtaining of affirmations of the ratings with respect to the existing credit facilities
(as modified by the Proposed Amendment) or ratings of the Replacement Facilities from each of Standard & Poor’s Ratings Service (“S&P”) and Moody’s Investors Service, Inc.
(“Moody’s) and the corporate rating from S&P and the corporate family rating from Moody’s, in each case in respect of the Borrower and (e) the hosting, with CS Securities, of one or more meetings of prospective
Lenders. You agree, at the request of CS Securities, to assist in the preparation of a version of the Confidential Information Memorandum and other marketing materials and presentations to be used in connection with the syndication of the
Facilities, consisting exclusively of information and documentation that is either (i) publicly available or (ii) not material with respect to the Borrower and its subsidiaries or any of their respective securities for purposes of United
States Federal and state securities laws (all such information and documentation being “Public Lender Information”). Any information and documentation that is not Public Lender Information is referred to herein as
“Private Lender Information”. You further agree that each document to be disseminated by Credit Suisse to any Lender in connection with the Facilities will be identified by you as either (i) containing Private Lender
Information or (ii) containing solely Public Lender Information, provided that Credit Suisse provides each such document in final form to the Borrower prior to its dissemination. 
 CS Securities will manage all aspects of any syndication, in consultation with the Borrower, including decisions as to the selection of institutions to
be approached (with the consent of the Borrower, such consent not to be unreasonably withheld or delayed) and when they will be approached, when their commitments will be accepted, which 
  

 3 

 institutions will participate (with the consent of the Borrower, such consent not to be unreasonably withheld or
delayed), the allocation of the commitments among the Lenders, any naming rights and the amount and distribution of fees among the Lenders. To assist CS Securities in its syndication efforts, you agree promptly to prepare and provide to CS
Securities all information with respect to you and your subsidiaries, the Transactions and the other transactions contemplated hereby, including all financial information and projections (the “Projections”), as we may
reasonably request. 
 4. Information. 
 You hereby represent and covenant (and it shall be a condition to CS’s commitment hereunder and our agreements to perform the services described herein) that (a) all information other than the Projections
(the “Information”) that has been or will be made available to Credit Suisse by or on behalf of you or any of your representatives is or will be, taken as a whole, complete and correct in all material respects and does not or
will not, taken as a whole, contain any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements contained therein not materially misleading in light of the circumstances under which such
statements are made and (b) the Projections that have been or will be made available to Credit Suisse by or on behalf of you or any of your representatives have been or will be prepared in good faith based upon accounting principles consistent
with your historical audited financial statements and upon assumptions that are reasonable at the time made and at the time the related Projections are made available to Credit Suisse. You agree that if at any time prior to the closing of the
Facilities any of the representations in the preceding sentence would be incorrect if the Information and Projections were being furnished, and such representations were being made, at such time, then you will promptly supplement the Information and
the Projections so that such representations will be correct under those circumstances. In arranging and syndicating the Facilities, we will be entitled to use and rely primarily on the Information and the Projections without responsibility for
independent verification thereof. 
 5. Fees. 
 As consideration for CS’s commitment hereunder and our agreements to perform the services described herein, you agree to pay to CS Securities the
fees set forth in this Commitment Letter and in the fee letter dated the date hereof and delivered herewith with respect to the Facilities (the “Fee Letter”). 
 6. Conditions Precedent. 
 CS’s commitment hereunder and agreement to perform the services described herein are subject to (a) there not having occurred any event, change or condition since December 31, 2005 that, individually or in the aggregate, has
had, or could reasonably be expected to have, a material adverse effect on the business, assets, liabilities, operations, condition (financial or otherwise), or operating results of you and your subsidiaries, taken as a whole, (b) our
satisfaction that, prior to and during the syndication of the Facilities, 
  

 4 

 there shall be no other issues of debt securities or commercial bank or other credit facilities of you or your
subsidiaries being offered, placed or arranged, (c) the negotiation, execution and delivery of definitive documentation with respect to the Facilities reasonably satisfactory to Credit Suisse and its counsel, (d) CS Securities having been
afforded a period of at least 21 consecutive days following the launch of the general syndication of the Facilities and immediately prior to the Closing Date to syndicate the Facilities (provided that such period shall not include any day
from and including December 18, 2006 through and including January 2, 2007), (e) your compliance with the terms of this Commitment Letter and the Fee Letter, and (f) the other conditions set forth or referred to in the Senior
Facilities Term Sheet and Exhibit D hereto. 
 7. Indemnification; Expenses. 
 You agree (a) to indemnify and hold harmless Credit Suisse and its affiliates and their respective officers, directors, employees, agents, advisors,
controlling persons, members and successors and assigns (each, an “Indemnified Person”) from and against any and all losses, claims, damages, liabilities and expenses, joint or several, to which any such Indemnified Person
may become subject arising out of or in connection with this Commitment Letter, the Fee Letter, the Transactions, the Facilities or any related transaction or any claim, litigation, investigation or proceeding relating to any of the foregoing,
regardless of whether any such Indemnified Person is a party thereto (and regardless of whether such matter is initiated by a third party or by you or any of your affiliates), and to reimburse each such Indemnified Person upon demand for any
reasonable legal or other expenses incurred in connection with investigating or defending any of the foregoing, provided that the foregoing indemnity will not, as to any Indemnified Person, apply to losses, claims, damages, liabilities or
related expenses to the extent they are found in a final, non-appealable judgment of a court of competent jurisdiction to have resulted from the willful misconduct or gross negligence of such Indemnified Person, and (b) if the Closing Date
occurs, to reimburse Credit Suisse from time to time, upon presentation of a summary statement, for all reasonable out-of-pocket expenses (including but not limited to expenses of Credit Suisse’s due diligence investigation, consultants’
fees, syndication expenses, travel expenses and fees, disbursements and other charges of counsel), in each case incurred in connection with the Facilities and the preparation of this Commitment Letter, the Fee Letter, the definitive documentation
for the Facilities and any ancillary agreements and security arrangements in connection therewith. Notwithstanding any other provision of this Commitment Letter, no Indemnified Person shall be liable for any indirect, special, punitive or
consequential damages in connection with the Facilities. 
 8. Sharing Information; Absence of Fiduciary Relationship;
Affiliate Activities. 
 You acknowledge that Credit Suisse and its affiliates may be providing debt financing, equity capital or other
services (including financial advisory services) to other companies in respect of which you may have conflicting interests regarding the transactions described herein or otherwise. Neither we nor any of our affiliates will use 
  

 5 

 confidential information obtained from you by virtue of the transactions contemplated by this Commitment Letter or our
other relationships with you in connection with the performance by us of services for other companies, and we will not furnish any such information to other companies. You also acknowledge that neither we nor any of our affiliates has any obligation
to use in connection with the transactions contemplated by this Commitment Letter, or to furnish to you, confidential information obtained by us from other companies. 
 You further acknowledge and agree that (a) no fiduciary, advisory or agency relationship between you and Credit Suisse is intended to be or has been created in respect of any of the transactions contemplated by
this Commitment Letter, irrespective of whether Credit Suisse and/or its affiliates have advised or are advising you on other matters, (b) Credit Suisse, on the one hand, and you, on the other hand, have an arms-length business relationship
that does not directly or indirectly give rise to, nor do you rely on, any fiduciary duty on the part of Credit Suisse, (c) you are capable of evaluating and understanding, and you understand and accept, the terms, risks and conditions of the
transactions contemplated by this Commitment Letter, (d) you have been advised that Credit Suisse and its affiliates are engaged in a broad range of transactions that may involve interests that differ from your interests and that Credit Suisse
has no obligation to disclose such interests and transactions to you by virtue of any fiduciary, advisory or agency relationship, and (e) you waive, to the fullest extent permitted by law, any claims you may have against Credit Suisse for
breach of fiduciary duty or alleged breach of fiduciary duty and agree that Credit Suisse shall have no liability (whether direct or indirect) to you in respect of such a fiduciary duty claim or to any person asserting a fiduciary duty claim on
behalf of or in right of you, including your stockholders, employees or creditors. 
 You acknowledge that Credit Suisse is a full service
securities firm engaged in securities trading and brokerage activities as well as providing investment banking and other financial services. In the ordinary course of business, Credit Suisse and its affiliates may provide investment banking and
other financial services to, and/or acquire, hold or sell, for their own accounts and the accounts of customers, equity, debt and other securities and financial instruments (including bank loans and other obligations) of, the Borrower and other
companies with which the Borrower may have commercial or other relationships. With respect to any securities and/or financial instruments so held by Credit Suisse or any of its affiliates or customers, all rights in respect of such securities and
financial instruments, including any voting rights, will be exercised by the holder of the rights, in its sole discretion. 
 9. Assignments, Amendments, Governing Law, Etc. 
 This Commitment Letter shall not be assignable by you without the prior
written consent of CS and CS Securities (and any attempted assignment without such consent shall be null and void), is intended to be solely for the benefit of the parties hereto (and Indemnified Persons) and is not intended to confer any benefits
upon, or create any rights in favor of, any person other than the parties hereto (and Indemnified Persons). With the 
  

 6 

 consent of the Borrower (not to be unreasonably withheld or delayed), CS may assign its commitment hereunder to one or
more prospective Lenders, whereupon CS shall be released from the portion of its commitment hereunder so assigned. Any and all obligations of, and services to be provided by, Credit Suisse hereunder (including, without limitation, CS’s
commitment) may be performed and any and all rights of Credit Suisse hereunder may be exercised by or through any of its affiliates or branches. This Commitment Letter may not be amended or any provision hereof waived or modified except by an
instrument in writing signed by CS, CS Securities and you. This Commitment Letter may be executed in any number of counterparts, each of which shall be an original and all of which, when taken together, shall constitute one agreement. Delivery of an
executed counterpart of a signature page of this Commitment Letter by facsimile transmission shall be effective as delivery of a manually executed counterpart hereof. Paragraph headings used herein are for convenience of reference only, are not part
of this Commitment Letter and are not to affect the construction of, or to be taken into consideration in interpreting, this Commitment Letter. You acknowledge that information and documents relating to the Facilities may be transmitted through
Syndtrak, Intralinks, the internet, e-mail or similar electronic transmission systems, and that Credit Suisse shall not be liable for any damages arising from the unauthorized use by others of information or documents transmitted in such manner,
except to the extent resulting from the willful misconduct or gross negligence of Credit Suisse. This Commitment Letter and the Fee Letter supersede all prior understandings, whether written or oral, between us with respect to the Facilities.
THIS COMMITMENT LETTER SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH, THE LAWS OF THE STATE OF NEW YORK. 
 10. Jurisdiction. 
 Each of the parties hereto hereby irrevocably and unconditionally (a) submits, for itself and its
property, to the exclusive jurisdiction of any New York State court or Federal court of the United States of America sitting in New York City, and any appellate court from any thereof, in any action or proceeding arising out of or relating
to this Commitment Letter, the Fee Letter or the transactions contemplated hereby or thereby and agrees that all claims in respect of any such action or proceeding may be heard and determined only in such New York State court or, to the extent
permitted by law, in such Federal court (provided that suit for the recognition or enforcement of any judgment obtained in any such New York State or Federal court may be brought in any other court of competent jurisdiction), (b) waives,
to the fullest extent it may legally and effectively do so, any objection which it may now or hereafter have to the laying of venue of any suit, action or proceeding arising out of or relating to this Commitment Letter, the Fee Letter or the
transactions contemplated hereby or thereby in any New York State court or in any such Federal court and (c) waives, to the fullest extent permitted by law, the defense of an inconvenient forum to the maintenance of such action or
proceeding in any such court. Service of any process, summons, notice or document by registered mail addressed to you at the address above shall be effective service of process against you for any suit, action or proceeding brought in any such
court. 
  

 7 

 11. Waiver of Jury Trial. 
 EACH OF THE PARTIES HERETO IRREVOCABLY WAIVES THE RIGHT TO TRIAL BY JURY IN ANY ACTION, PROCEEDING, CLAIM OR COUNTERCLAIM BROUGHT BY OR ON BEHALF OF
ANY PARTY RELATED TO OR ARISING OUT OF THIS COMMITMENT LETTER, THE FEE LETTER OR THE PERFORMANCE OF SERVICES HEREUNDER OR THEREUNDER. 
 12. Confidentiality. 
 This Commitment Letter is delivered to you on the understanding that neither
this Commitment Letter nor the Fee Letter nor any of their terms or substance, nor the activities of Credit Suisse pursuant hereto, shall be disclosed, directly or indirectly, to any other person except (a) to your officers, directors,
employees, attorneys, accountants and advisors on a confidential and need-to-know basis or (b) as required by applicable law or compulsory legal process (in which case you agree to inform us promptly thereof). 
 Notwithstanding anything herein to the contrary, any party to this Commitment Letter (and any employee, representative or other agent of such party) may
disclose to any and all persons, without limitation of any kind, the tax treatment and tax structure of the transactions contemplated by this Commitment Letter and the Fee Letter and all materials of any kind (including opinions or other tax
analyses) that are provided to it relating to such tax treatment and tax structure, except that (i) tax treatment and tax structure shall not include the identity of any existing or future party (or any affiliate of such party) to this
Commitment Letter or the Fee Letter, and (ii) no party shall disclose any information relating to such tax treatment and tax structure to the extent nondisclosure is reasonably necessary in order to comply with applicable securities laws. For
this purpose, the tax treatment of the transactions contemplated by this Commitment Letter and the Fee Letter is the purported or claimed U.S. Federal income tax treatment of such transactions and the tax structure of such transactions is any fact
that may be relevant to understanding the purported or claimed U.S. Federal income tax treatment of such transactions. 
 13. Surviving Provisions. 
 The compensation, reimbursement, indemnification, confidentiality, jurisdiction and waiver of
jury trial provisions contained herein and in the Fee Letter shall remain in full force and effect notwithstanding the termination of this Commitment Letter or CS’s commitment hereunder. If definitive documentation relating to the Facilities
shall be executed and delivered, your obligations under this Commitment Letter in respect of the applicable Facilities, other than those relating to confidentiality and to the syndication of such Facilities (which shall remain in full force and
effect), shall automatically terminate and be superseded by the provisions contained in such definitive documentation upon the execution and delivery thereof. 
  

 8 

 14. PATRIOT Act Notification. 
 Credit Suisse hereby notifies you that pursuant to the requirements of the USA PATRIOT Act, Title III of Pub. L. 107-56 (signed into law October 26,
2001) (the “PATRIOT Act”), Credit Suisse and each Lender is required to obtain, verify and record information that identifies the Borrower, which information includes the name, address, tax identification number and other
information regarding the Borrower that will allow Credit Suisse or such Lender to identify the Borrower in accordance with the PATRIOT Act. This notice is given in accordance with the requirements of the PATRIOT Act and is effective as to Credit
Suisse and each Lender. 
 15. Acceptance and Termination. 
 If the foregoing correctly sets forth our agreement, please indicate your acceptance of the terms of this Commitment Letter and of the Fee Letter by
returning to us executed counterparts hereof and of the Fee Letter not later than 5:00 p.m., New York City time, on December 18, 2006. CS’s commitment hereunder and the agreements of CS and CS Securities contained herein will
expire at such time in the event that Credit Suisse has not received such executed counterparts in accordance with the immediately preceding sentence. In the event that the borrowing in respect of the Additional Term Loans (or if the Proposed
Amendment is not obtained, the Replacement Facilities) does not occur on or before March 31, 2007, then this Commitment Letter and CS’s commitment and the undertakings of CS and CS Securities hereunder shall automatically terminate unless
Credit Suisse shall, in its discretion, agree to an extension. 
 [Remainder of this page intentionally left blank] 
  

 9 

 Credit Suisse is pleased to have been given the opportunity to assist you in connection with the
financing for the Transactions. 
  

			
	Very truly yours,
	
	CREDIT SUISSE SECURITIES (USA) LLC
		
	By	 	 /s/ James S. Finch
  

	Name:	 	James S. Finch
	Title:	 	Managing Director
	
	CREDIT SUISSE, CAYMAN ISLANDS BRANCH
		
	By	 	 /s/ Sarah Wu
  

	Name:	 	Sarah Wu
	Title:	 	Director
		
	By	 	 /s/ Cassandra Droogan
  

	Name:	 	Cassandra Droogan
	Title:	 	Vice President

  

			
	Accepted and agreed to as of the date first above written:
	
	WEIGHT WATCHERS INTERNATIONAL, INC.
		
	By	 	 /s/ Ann Sardini
  

	Name:	 	Ann Sardini
	Title:	 	Chief Financial Officer

  

 10 

			
	 CONFIDENTIAL
 December 15, 2006
	  	EXHIBIT A

 Weight Watchers International, Inc. 
 $2,050,000,000 Senior Secured Replacement Credit Facilities 
 Summary of
Principal Terms and Conditions 
 If the Proposed Amendment (as defined below) is obtained, the Borrower will obtain Designated
Additional Term A-1 Loans in an aggregate principal amount of up to $700,000,000 and Designated Additional Term B Loans in an aggregate principal amount of up to $500,000,000 which funds will be used to fund the Self Tender and Affiliate Purchase,
repay in full the Subsidiary Credit Agreements and pay Transaction Costs. Such Designated Additional Term A-1 Loans are expected to be on the terms of the Existing Credit Agreement (as amended pursuant to the Proposed Amendment) and otherwise as
agreed by the Borrower and the Arranger (and, to the extent applicable, substantially as described in this Exhibit A with respect to the Term A Facility (including, for the avoidance of doubt, with respect to maturity)). Such Designated Additional
Term B Loans are expected to be on the terms of the Existing Credit Agreement (as amended pursuant to the Proposed Amendment) and otherwise as agreed by the Borrower and the Arranger (and, to the extent applicable, substantially as described in this
Exhibit A with respect to the Term B Facility). The approximate sources and uses in respect of the Designated Additional Term A-1 Loans and the Designated Additional Term B Loans are expected to be as set forth in Exhibit B. If the Proposed
Amendment is not obtained, the Borrower will obtain the Replacement Facilities described below. 
  

					
	Borrower:	  		  	Weight Watchers International, Inc., a Virginia corporation (the “Borrower”).
			
	Transactions:	  		  	The Borrower intends to (a) make a public tender offer to acquire, and enter into an agreement with an affiliate of the Borrower to acquire, a portion of its outstanding common stock for
an aggregate purchase price not to exceed $1,000,000,000 (the “Self Tender and Affiliate Purchase”) and (b) repay all outstanding indebtedness under, and terminate, (i) the First Lien Credit Agreement dated as of
December 16, 2005, among Weightwatchers.com, Inc., the lenders party thereto and CS, as administrative agent (the “Subsidiary First Lien Credit Agreement”), and (ii) the Second Lien Credit Agreement dated as of December
16, 2005, among Weightwatchers.com, Inc., the lenders party thereto and CS, as administrative agent (together with the Subsidiary First Lien Credit Agreement, the “Subsidiary Credit Agreements”).

					
		  		  	 In connection with the foregoing, (a) either (i) the Sixth Amended and Restated Credit Agreement dated as of May 8, 2006 (the
“Existing Credit Agreement”), among the Borrower, the lenders party thereto and The Bank of Nova Scotia, as administrative agent, will be amended to, among other things, (x) permit the Self Tender and Affiliate Purchase
and the repayment and termination of the Subsidiary Credit Agreements and the financing therefor, (y) increase (and modify the pricing grid) the interest rate margins for the revolving loans and term A loans in the manner described under the
heading “Changes in Interest Rate Margins and Commitment Fees” in Annex I to this Exhibit A and (z) add an excess cash flow sweep as a mandatory prepayment as described under the heading “Mandatory Prepayments”
below (collectively, the “Proposed Amendment”), and the Borrower will obtain incremental term A-1 loans (the “Designated Additional Term A-1 Loans”) under the Existing Credit Agreement in an aggregate
principal amount of up to $700,000,000 and incremental term B loans (the “Designated Additional Term B Loans”) under the Existing Credit Agreement in an aggregate principal amount of up to $500,000,000 or (ii) the Borrower
will prepay in full, and terminate, the Existing Credit Agreement using the proceeds of the senior secured replacement credit facilities described below under the caption “Senior Secured Replacement Credit Facilities” (the
“Replacement Facilities”) for such purpose and to make the Self Tender and Affiliate Purchase and repay the Subsidiary Credit Agreements and (b) fees and expenses incurred in connection with the foregoing (the
“Transaction Costs”) will be paid.
  
 The transactions described
in the preceding two paragraphs are collectively referred to herein as the “Transactions”.

			
	Sources and Uses:	  		  	The approximate sources and uses of the funds necessary to consummate the Transactions are set forth in Exhibit C to the Commitment Letter the “Commitment
Letter”) to which this Term Sheet is attached.

  

 2 

					
	Agent:	 	Credit Suisse, acting through one or more of its branches or affiliates (“CS”), will act as sole administrative agent and collateral agent (collectively, in such
capacities, the “Agent”), it being understood that the Borrower may instead select The Bank of Nova Scotia or, if reasonably acceptable to CS, another Lender, to act as the Agent, for a syndicate of banks, financial
institutions and other institutional lenders (together with CS, the “Lenders”), and will perform the duties customarily associated with such roles.
		
	 Sole Bookrunner and Sole
 Lead
Arranger:
	 	    
Credit Suisse Securities (USA) LLC will act as sole bookrunner and sole lead arranger for the Replacement Facilities (the “Arranger”), and
will perform the duties customarily associated with such roles.
		
	Syndication Agent:	 	At the option of the Arranger, a financial institution identified by the Arranger and acceptable to the Borrower (the “Syndication Agent”).
		
	Documentation Agent:	 	At the option of the Arranger, a financial institution identified by the Arranger and acceptable to the Borrower (the “Documentation Agent”).
			
	 Senior Secured
 Replacement Credit

 Facilities:
	  	    
    
(A)	 	    
    
A senior secured term A loan facility in an aggregate principal amount of up to $1,050,000,000 (the “Term A
Facility”).
			
		  	(B)	 	A senior secured term B loan facility in an aggregate principal amount of up to $500,000,000 (the “Term B Facility” and, together with the Term A Facility, the
“Term Facilities”).

  

 3 

					
		  	(C)	 	 A senior secured revolving credit facility in an aggregate principal amount of up to $500,000,000 (the “Revolving
Facility” and, together with the Term Facilities, the “Senior Facilities”), of which up to $25,000,000 will be available through a subfacility in the form of letters of credit.
  
 In connection with the Revolving Facility, CS (in such capacity, the “Swingline
Lender”) will make available to the Borrower a swingline facility under which the Borrower may make short-term borrowings of up to $15,000,000. Except for purposes of calculating the Commitment Fee described in Annex I hereto, any such
swingline borrowings will reduce availability under the Revolving Facility on a dollar-for-dollar basis. Each Lender under the Revolving Facility shall, promptly upon request by the Swingline Lender, fund to the Swingline Lender its pro rata share
of any swingline borrowings.

			
	Incremental Facility:	  		 	The Borrower shall be entitled on one or more occasions and subject to satisfaction of customary conditions to incur additional term loans (the “Additional Term
Loans”) under the Term A Facility or the Term B Facility and/or to obtain additional revolving commitments (the “Additional Revolving Commitments”) under the Revolving Facility or under a new tranche of revolving
loans in an aggregate principal amount of up to $400,000,000 on terms substantially as provided for in the Existing Credit Agreement (as modified to reflect the Term B Facility (including its maturity date)).

  

 4 

					
	Purpose:	  	(A)	 	The proceeds of the Term Facilities will be used by the Borrower, on the date of the borrowing under the Term Facilities (the “Closing Date”) (provided that up
to $575,000,000 of the Term A Facility may be drawn in a second drawing on a date up to three weeks following the Closing Date) solely (a) to repay in full and terminate the Existing Credit Agreement and the Subsidiary Credit Agreements, (b) to fund
the Self Tender and Affiliate Purchase and (c) to pay the Transaction Costs.
			
		  	(B)	 	The proceeds of loans under the Revolving Facility will be used by the Borrower on the Closing Date as provided in clause (A) above, and thereafter from time to time for general corporate
purposes.
			
		  	(C)	 	Letters of credit will be used solely to support payment obligations incurred in the ordinary course of business by the Borrower and its Subsidiaries.
			
	Availability:	  	(A)	 	The full amount of each of the Term Facilities must be drawn in a single drawing on the Closing Date; provided that up to $575,000,000 of the Term A Facility may be drawn in a second
drawing on a date up to three weeks following the Closing Date. Amounts borrowed under the either of the Term Facilities that are repaid or prepaid may not be reborrowed.
			
		  	(B)	 	Loans of up approximately $307,500,000 (or such other amount as may be required in order to refinance the Borrower’s existing revolving credit facility) may be made under the Revolving
Facility on the Closing Date. Thereafter, loans under the Revolving Facility will be available at any time prior to the final maturity of the Revolving Facility, in a minimum principal amount of $2,000,000 and integral multiples of $500,000 in
excess thereof (in the case of Adjusted LIBOR borrowings) or in a minimum principal amount of $500,000 and integral multiples in excess thereof (in the case of ABR borrowings). Amounts repaid under the Revolving Facility may be
reborrowed.

  

 5 

							
	Letters of Credit:	 	Letters of credit under the Revolving Facility will be issued by CS, The Bank of Nova Scotia, JPMorgan Chase Bank, N.A. or another Lender acceptable to the Borrower and the Agent
(the “Issuing Bank”). Each letter of credit shall expire not later than the earlier of (a) 12 months after its date of issuance and (b) the final maturity of the Revolving Facility; provided, however,
that any letter of credit may provide for renewal thereof for additional periods of up to 12 months (which in no event shall extend beyond the date referred to in clause (b) above).
		
		 	Drawings under any letter of credit shall be reimbursed by the Borrower on the same business day. To the extent that the Borrower does not reimburse the Issuing Bank on the same
business day, the Lenders under the Revolving Facility shall be irrevocably obligated to reimburse the Issuing Bank pro rata based upon their respective Revolving Facility commitments.
		
	Interest Rates:	 	As set forth on Annex I hereto.
		
	Default Rate:	 	The applicable interest rate plus 2.0% per annum, on overdue amounts.
			
	 Final Maturity
 and
Amortization:
	  	    
(A)	 	     
Term A Facility
  
 The Term A Facility will mature on the date that is six years after the Closing Date, and will amortize in equal quarterly installments in an aggregate annual amount
equal to the percentage of the original principal amount of the Term A Facility set forth below opposite the applicable year:

  

								
	  	  	 Year
	  	Percentage	 
	  	Year 1	  	0	%
	  	Year 2	  	0	%
	  	Year 3	  	15	%
	  	Year 4	  	20	%
	  	Year 5	  	25	%
	  	Year 6	  	40	%

  

 6 

					
		  	(B)	  	 Term B Facility
  
 The Term B Facility will mature on the date that is seven years after the Closing Date, and will amortize in equal quarterly installments in an aggregate annual amount
equal to 1% of the original principal amount of the Term B Facility with the balance payable on the maturity date of the Term B Facility.

			
		  	(C)	  	 Revolving Facility
  
 The Revolving Facility will mature and the commitments thereunder will terminate on June 30, 2011.

		
	Guarantees and Security:	  	The Senior Facilities will be guaranteed and secured by the same entities and collateral, respectively, that guarantee and secure the loans and other obligations under the Existing Credit
Agreement, all on a pari passu basis; provided that there shall be provisions for a release of collateral on terms substantially similar to those in the Existing Credit Agreement.
		
	Mandatory Prepayments:	  	The mandatory prepayment provisions in respect of the Term Loans will be substantially similar to those in the Existing Credit Agreement (with the Term A Facility and Term B Facility being
repaid on a pro rata basis); provided that the Term Loans shall be prepaid with 50% of Excess Cash Flow (to be defined, including offsets for franchise acquisitions) (which amount shall be reduced to (i) 25% in the event the Net Debt to
EBITDA Ratio is between 3.5 to 1.0 and 4.5 to 1.0 and (ii) 0% in the event the Net Debt to EBITDA Ratio is less than 3.5 to 1.0); provided, further, that any mandatory prepayments due from Excess Cash Flow in any fiscal year shall be
offset by any voluntary prepayments made in such fiscal year.
		
	Voluntary Prepayments:	  	Voluntary prepayments of borrowings under the Term Facilities will be permitted at any time, in minimum principal amounts consistent with the Existing Credit Agreement, without premium or
penalty, subject to reimbursement of the Lenders’ redeployment costs in the case of a prepayment of Adjusted LIBOR borrowings other than on the last day of the relevant interest period. All voluntary prepayments will be applied at the direction
of the Borrower.

  

 7 

					
	 Representations and
 Warranties:
	  		  	    
Substantially as provided for in the Existing Credit Agreement.
			
	 Conditions Precedent to
 Borrowing:
	  		  	     
Substantially as provided for in the Existing Credit Agreement.
 The borrowing under the Senior Facilities will also be subject to the conditions precedent set forth in Exhibit D to the Commitment Letter.

			
	Affirmative and Negative Covenants, Defaults and Miscellaneous Provisions:	  		  	    
    
Substantially as provided for in the Existing Credit Agreement.
			
	Financial Covenants:	  		  	Substantially as provided for in the Existing Credit Agreement with levels to be agreed.
			
	Voting:	  		  	Substantially as provided for in the Existing Credit Agreement; provided that certain amendments and waivers shall require class voting.
			
	Governing Law and Forum:	  		  	New York.
			
	 Counsel to Agent and
 Arranger:
	  		  	Cravath, Swaine & Moore LLP.

  

 8 

 ANNEX I 
  

					
	Interest Rates:	  		  	 Term B Facility
  
 The interest rates under the Term B Facility will be Adjusted LIBOR plus 1.50% or ABR plus 0.50%.
  
 Term A Facility and Revolving Facility
  
 The interest rates under the Term A Facility and the Revolving Facility will be Adjusted LIBOR plus
1.25% or ABR plus 0.25%.
  
 The Borrower may elect interest periods of 1, 2, 3 or 6 (or 9
or 12, if agreed to by the Lenders) months for Adjusted LIBOR borrowings.
  
 Calculation
of interest shall be on the basis of the actual days elapsed in a year of 360 days (or 365 or 366 days, as the case may be, in the case of ABR loans based on the Prime Rate) and interest shall be payable at the end of each interest period and, in
any event, at least every three months.
  
 ABR is the Alternate Base Rate, which is the
higher of Credit Suisse’s Prime Rate and the Federal Funds Effective Rate plus  1/2 of
1.0%.
  
 Adjusted LIBOR will at all times include statutory
reserves.

			
	Letter of Credit Fees:	  		  	A per annum fee equal to the spread over Adjusted LIBOR under the Revolving Facility will accrue on the aggregate face amount of outstanding letters of credit under the Revolving Facility,
payable in arrears at the end of each quarter and upon the termination of the Revolving Facility, in each case for the actual number of days elapsed over a 360-day year. Such fees shall be distributed to the Lenders participating in the Revolving
Facility pro rata in accordance with the amount of each such Lender’s Revolving Facility commitment. In addition, the Borrower shall pay to the Issuing Bank, for its own account, (a) a fronting fee equal to a percentage per annum to be agreed
upon of the aggregate face amount of outstanding letters of credit, payable in arrears at the end of each quarter and upon the termination of the Revolving Facility, calculated based upon the actual number of days elapsed over a 360-day year, and
(b) customary issuance and administration fees.

											
	Commitment Fees:	  		  	0.25% per annum on the undrawn portion of the commitments in respect of the Revolving Facilities, payable quarterly in arrears after the Closing Date and upon the termination of
the commitments, calculated based on the number of days elapsed in a 360-day year.
			
	 Changes in Interest Rate Margins
 and
Commitment Fees:
	  		  	    
The definitive credit documentation for the Senior Facilities will contain provisions under which, from and after the Closing Date, and so long as no
default shall have occurred and be continuing, interest rate margins under the Revolving Facility and Term A Facility and commitment fees under the Revolving Facility will be subject to change in increments based on the Net Debt to EBITDA Ratio, as
set forth below:

  

												
	 	  	 Net Debt to
 EBITDA
 Ratio
	  	 Adjusted
LIBOR
 Margin
	 	 	 Base
Rate
 Margin
	 	 	Commitment
Fee	 
	  	>3.25 to 1.00	  	1.25	%	 	0.25	%	 	0.25	%
	  	2.00 to 1.00—3.25 to 1.00	  	1.00	 	 	0.00	%	 	0.20	%
	  	1.50 to 1.00—2.00 to 1.00	  	0.875	%	 	0.00	%	 	0.175	%
	  	<1.50 to 1.0	  	0.75	%	 	0.00	%	 	0.15	%

  

 2 

 EXHIBIT B 
 Sources and Uses of Funds 
 (Designated Additional Term A-1 Loans and Designated Additional Term B Loans)

 (in millions of dollars) 
 (all
figures are approximate) 
  

									
	 Sources of Funds
	  	 Uses of Funds

	 Term A-1 Facility
	  	$	700.0	  	Self Tender and Affiliate Purchase	  	$	1,000.0
	 Term B Facility
	  	 	500.0	  	Transaction Costs	  	 	8.0
		  			  	Refinance Subsidiary Existing Credit Agreements	  	 	187.7
		  			  	Cash on Balance Sheet	  	 	4.3
	 Total Sources
	  	$	1,200.0	  	Total Uses	  	$	1,200.0
		  	 	 	  		  	 	 

  

 EXHIBIT C 
 Sources and Uses of Funds 
 (Replacement Facilities) 
 (in millions of dollars) 
 (all figures are approximate) 
  

									
	 Sources of Funds
	  	 Uses of Funds

	 Term A Facility
	  	$	1,050.0	  	Self Tender and Affiliate Purchase	  	$	1,000.0
	 Term B Facility
	  	 	500.0	  	Transaction Costs	  	 	8.0
	 Revolving Facility1
	  	 	307.5	  	Refinance existing term A facility	  	 	350.0
		  			  	Refinance existing revolving facility	  	 	307.5
		  			  	Refinance Subsidiary Existing Credit Agreements	  	 	187.7
		  			  	Cash on Balance Sheet	  	 	4.3
	 Total Sources
	  	$	1,857.5	  	Total Uses	  	$	1,857.5
		  	 	 	  		  	 	 

	1	Represents approximate amount to be drawn under the $500,000,000 Revolving Facility on the Closing Date. The actual amount will be the amount required to refinance
the Borrower’s existing revolving facility. 

  

 EXHIBIT D 
 Weight Watchers International, Inc. 
 $2,050,000,000 Senior Secured Replacement Credit
Facilities 
 Summary of Additional Conditions Precedent1 
 The borrowing
under the Facilities shall be subject to the following additional conditions precedent: 
 1. The Self Tender and Affiliate Purchase (other
than with respect to the portion of such transaction in respect of the purchase of shares from an affiliate) and the other Transactions shall be consummated substantially simultaneously with the closing under the Facilities in accordance with
applicable law and on the terms described in the Term Sheets. 
 2. After giving effect to the Transactions and the other transactions
contemplated hereby, the Borrower and its subsidiaries shall have outstanding no indebtedness or preferred stock other than (a) the loans under the Facilities and (b) other limited indebtedness to be agreed upon. 
 3. The Agent shall have received U.S. GAAP unaudited consolidated balance sheets and related statements of income, stockholders’ equity and cash
flows of the Borrower for each subsequent fiscal quarter ended 45 days before the Closing Date. 
 4. The Agent shall have received a
certificate from the chief financial officer of the Borrower certifying that the Borrower and its subsidiaries, on a consolidated basis after giving effect to the Transactions and the other transactions contemplated hereby, are solvent. 

5. All requisite governmental authorities and third parties shall have approved or consented to the Transactions and the other transactions
contemplated hereby to the extent required, all applicable appeal periods shall have expired and there shall be no litigation, governmental, administrative or judicial action, actual or threatened, that could reasonably be expected to restrain,
prevent or impose burdensome conditions on the Transactions or the other transactions contemplated hereby. 
 6. The Agent shall have
received, at least five business days prior to the Closing Date, all documentation and other information required by regulatory authorities under applicable “know your customer” and anti-money laundering rules and regulations, including
without limitation the PATRIOT Act. 
  

	1	All capitalized terms used but not defined herein have the meanings given to them in the Commitment Letter to which this Exhibit D is attached, including Exhibit A
thereto.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00115-of-00352.parquet"}]]